Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database

Abstract Aims/Introduction Severe diabetic macular edema (DME) is often resistant to anti‐vascular endothelial growth factor therapy. Steroids are particularly effective at reducing edema by suppressing inflammation; they are also used as an alternative to expensive anti‐vascular endothelial growth...

Повний опис

Бібліографічні деталі

Автори:	Ryoichi Ishibashi, Masaya Koshizaka, Yoko Takatsuna, Tomoaki Tatsumi, Yoshiro Maezawa, Yuki Shiko, Yosuke Inaba, Yohei Kawasaki, Yusuke Kashiwagi, Eiryo Kawakami, Shuichi Yamamoto, Koutaro Yokote
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Wiley 2024-09-01
Серія:	Journal of Diabetes Investigation
Предмети:	Diabetic macular edema Sodium–glucose cotransporter 2 inhibitor Steroid injection
Онлайн доступ:	https://doi.org/10.1111/jdi.14253
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!